Researchers apply for single-dose HIV vaccine patent; A rundown of promising therapeutic cancer vaccines;

> Researchers at the Texas Biomedical Research Institute in San Antonio applied for a patent for a single-dose HIV vaccine. Story

> Argos Therapeutics published a study in the Journal of Pharmaceutical and Biomedical Analysis confirming that its manufacturing and quality control systems for RNA analysis are optimal as the company further advances its AGS-003 immunotherapy in clinical development for the treatment of mRCC. Release

> Allied Healthcare Group, an Australian biomedical company, announced positive trial results for its HPV vaccine. News

> A single dose of Medicago's H5N1 VLP vaccine protected against additional pandemic flu strains in a preclinical study. Release

And Finally... Seeking Alpha offers a rundown of therapeutic cancer vaccines that show real promise. Article

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.